Anaphylaxis is a rare reaction in COVID-19 vaccination.

Bellomo, R G; Gallenga, C E; Caraffa, Al; Tetè, G; Ronconi, G; Conti, P

Bellomo, R G; Gallenga, C E; Caraffa, Al; Tetè, G; Ronconi, G; Conti, P.

Afiliación

Bellomo RG; University of Study of Urbino Carlo Bo, Department of Biomolecular Sciences, Urbino, Italy.
Gallenga CE; Molecular Medicine, Department of Morphology, Surgery, Experimental Medicine, University of Ferrara, Ferrara, Italy.
Caraffa A; School of Pharmacy, University of Camerino, Camerino, Italy.
Tetè G; Specialization School in Oral Surgery, Vita-Salute San Raffaele University, Milan, Italy.
Ronconi G; Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
Conti P; Postgraduate Medical School, University of Chieti, Chieti, Italy.

J Biol Regul Homeost Agents ; 35(3): 839-842, 2021.

Article en En | MEDLINE | ID: mdl-34105336

Asunto(s)

Anafilaxia; COVID-19; Vacunas contra la COVID-19; Femenino; Humanos; SARS-CoV-2; Vacunación/efectos adversos

Palabras clave

COVID-19; SARS-CoV-2; allergy; anaphylaxis; immunity; inflammation; vaccine

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 / Anafilaxia Límite: Female / Humans Idioma: En Revista: J Biol Regul Homeost Agents Asunto de la revista: BIOLOGIA / BIOQUIMICA Año: 2021 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Italia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google